Revolutionizing the provision of patient care, improving outcomes and reducing overall cost through new medical technologies is serious business. It takes vision, technical prowess and efficient use of scarce resources in a rigorous regulatory landscape. Last month, The New York Times included the work GCMI and the American Cancer Society are doing with Dr. Darren…
Last year, Ares Health Systems became the first digital health company to enter GCMI’s accelerator, accessing our digital health commercial development expertise and health system relationships to further validate the value of Ares’ MPower care management platform and commence market penetration. “Our confidence in our value proposition has increased since we’ve last talked,” says Ares…
The American Academy of Orthopaedic Surgeons’ Annual Meeting (AAOS) is the premier ortho event of the year: hosting thousands of thought leaders, physicians, scientists and academics seeking the latest in injury prevention and disease treatment of the musculoskeletal system. AAOS 2019 will once again bring the top names in orthopedics together in Las Vegas March…
It might not be the deal monster JPMorgan has become, but one could argue HIMSS is as important, and as noisy, as any other event in healthcare. Our intrepid colleagues Martin Entwistle, president and CEO of Ares Health Systems and Andrew Stevenson, executive director for GCMI braved HIMSS 2019. Their focus: demonstrating the market attractiveness…
February 14, 2019 (Atlanta, GA) – Georgia Bio, the state’s life science trade association, named GCMI and Rambam Medical Center 2019 Phoenix Award winners. Part of the Georgia Bio’s annual Golden Helix Award program, the Phoenix Award recognizes leaders who have forged academic and industry relationships that will drive translation, leading to new treatments and…
Andrew Stevenson, GCMI Executive Director, will be attending the 2019 Healthcare Information and Management Systems Society (HIMSS) Global Conference & Exhibition on February 11–15 in Orlando to discuss GCMI’s “A1” accelerator program. Martin Entwistle, Ares Health Systems CEO, will also be accompanying Andrew to this conference. Ares Health Systems was the first digital health startup…
Another edition of the biggest event in the business of healthcare has come and gone. While more attendees are questioning its value given the size, noise and expense, in this Q&A GCMI CEO Tiffany Wilson shares her JP Morgan 2019 insights, advice and a look ahead to 2020. What was most valuable for you at…
GCMI’s 2018 year end review and 2019 look ahead Thanks to our staff, customers, sponsors and fellow industry, academic and philanthropic visionaries, GCMI has tangibly advanced our mission of accelerating the development, testing, training and commercialization of innovative medical products that improve quality based outcomes and delivery of healthcare for patients. 2018 Highlights Leading…
Medtech Women @ SEMDA branched out to Memphis on November 7th bringing the ecosystem together to discuss addressable gaps and tools needed to enhance opportunities for advancement among women in medtech. The industry was well represented across multiple segments, company sizes and types. We would like to thank Memphis Bioworks for hosting the event. Memphis…
GCMI recently announced the formation of a medtech startup accelerator with Rambam Health Care Campus in Israel. Thanks to Hypepotamus for its coverage detailing how the project expands GCMI’s effort to accelerate global medtech innovation in a capital efficient way, building upon our existing A1 Accelerator. The support of Atlanta – Israel Business Connector “Connex”…